https://ipharmag.com/article/seattle-ai-biodesign-95m-protein-gene-design iPharmag en 2026-09-05T11:40:02+00:00 Seattle Institutes Launch a $95M Effort to Design Proteins and Genes That Don’t Exist in Nature https://ipharmag.com/article/pelacarsen-lpa-cardiovascular-trial-failure-novartis iPharmag en 2026-09-05T11:40:02+00:00 A Heart Drug Slashed a Genetic Risk Factor — but Didn’t Prevent Heart Attacks https://ipharmag.com/article/oracle-health-va-ehr-subpoena-cost-overrun iPharmag en 2026-09-05T11:40:02+00:00 Congress Subpoenas Oracle Health as VA Medical-Records Costs Nearly Triple https://ipharmag.com/article/etcamah-camizestrant-esr1-breast-cancer-fda-approval iPharmag en 2026-09-05T11:40:02+00:00 FDA Approves AstraZeneca’s Etcamah for Breast Cancer — Guided by a Blood Test for Resistance https://ipharmag.com/article/c-difficile-infant-gut-remodeling-lasting-effects iPharmag en 2026-09-05T11:40:02+00:00 A Gut Bacterium Long Thought Harmless in Babies May Reshape Their Intestines for Life https://ipharmag.com/article/tau-cd8-t-cells-lymph-nodes-alzheimers-neurodegeneration iPharmag en 2026-09-04T16:07:37+00:00 The Immune Cells That Worsen Alzheimer’s Damage Get Their Orders Outside the Brain https://ipharmag.com/article/ionis-zanvastro-zilganersen-alexander-disease-fda-approval iPharmag en 2026-09-04T16:07:37+00:00 FDA Approves the First-Ever Treatment for Alexander Disease https://ipharmag.com/article/gsk-hutchmed-hmpl-a830-kras-egfr-conjugate-deal iPharmag en 2026-09-04T16:07:37+00:00 GSK Pays Up to $1.3B for HUTCHMED’s Cancer Drug That Hits Two Targets at Once https://ipharmag.com/article/estradiol-patch-shortage-hrt-fda iPharmag en 2026-09-04T16:07:37+00:00 A US Shortage of Estradiol Patches Is Squeezing Menopause and Gender-Affirming Care https://ipharmag.com/article/egenesis-pig-kidney-xenotransplant-bridge-human-organ iPharmag en 2026-09-04T16:07:37+00:00 Pig-Kidney Recipients Later Got Human Organs — a Key Test for Animal-to-Human Transplants